Pieris Pharmaceuticals, Inc.
Q2 2024 13F Holders
Symbol
PIRS
CUSIP
720795202
Type
Equity
Class
COM NEW
Num filers
21
Total reported value, excl. options
$3.57M
Compare 2024 Q2 to
2025 Q2
2024 Q3
Manager
Report Date
Value ($000)
Shares
Option Type